Vallon Pharmaceuticals (VLON) Q4 2022 Earnings

24FebConfirmed
May 22
Jul 22
Nov 22
Q4 2022
-0.39
-0.29
-0.19
-0.09

Details

Expected EPS
N/A
Actual EPS
-0.1
Surprise EPS
-0.1
Surprise Percent
+∞%

Description

Vallon Pharmaceuticals (VLON) has reported earnings of -0.1 per share for Q4 2022.

0 Comments

Share your thoughts